Samuel Urrutia, MD, MS

Samuel Urrutia, MD, MS

Bone Marrow Transplant Specialist, Medical Oncologist

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, WashU Medicine

Clinical Expertise

MDS and AML

Research Interest

Dr. Samuel Urrutia is a physician and bionformatician. His research focuses on developing therapeutic strategies for myelodysplastic syndromes and acute myeloid leukemia as well as creating bioinformatic tools to better understand these conditions.

Education

  • 2016: MD, Universidad Nacional Autonoma de Honduras, Tegucigalpa, Honduras
  • 2024: MS, University of Texas Health and Science Center, Houston, TX

Training

  • 2018 - 2021: Internal Medicine Residency , Indiana University School of Medicine, Indianapolis, Indiana
  • 2021 - 2024: Hematology & Oncology Fellowship , The University of Texas Anderson Cancer Center. Houston, Texas

Board Certification

  • 2021: American Board of Internal Medicine

Selected Research Publications

Decitabine-cedazuridine in patients with MDS and TP53 mutations.
  • Urrutia S, Sasaki K, Bataller A, [...] Garcia-Manero G
  • Blood Adv 2026
Mortality and relapse dynamics in AML after three years of complete remission.
  • Urrutia S, Jen WY, Sasaki K, [...] Yilmaz M
  • Leuk Lymphoma 2025
A clinical guide to TP53 mutations in myeloid neoplasms.
  • Urrutia S, Wong TN, Link DC
  • Blood 2025
Cytogenetic annotation automation in myelodysplastic syndrome research databases.
  • Urrutia S, Chien KS, Li Z, [...] Garcia-Manero G
  • Blood Adv 2025

View All Publications

Contact Information

  • Gary C. Werths Building at Siteman Cancer Center

    4500 Forest Park Avenue
    Saint Louis, MO 63108

Request an appointment